Press "Enter" to skip to content

Anti-venom Market 2019 Significant Growth Rate by Industry Size, Share, Market Dynamics, Development Status of Key Players Forecast to 2024


The “Anti-venom Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Anti-venom industry. The information available in the Anti-venom market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Anti-venom market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Anti-venom Market:

  • Pfizer Inc.
  • Laboratorios Silanes (Bioclon Institute)
  • CSL Limited
  • Merck & Co.
  • Merck KGaA (Sigma Aldrich)
  • Flynn Pharma (Micropharm)
  • Boehringer Ingelheim

    Get a Sample Copy of the Report –

    Market Overview:

  • The anti-venom market is expected to register a CAGR of nearly 4.7% during the forecast period, 2019-2024.
  • – Snakebite is a neglected public health issue in many tropical and subtropical countries. About 5 million snake bites occur each year, resulting in up to 2.5 million envenoming’s (poisoning from snake bites) and at least 100,000 deaths, and around three times as many amputations and other permanent disabilities.
  • – Due to the involvement of international health organizations in producing safe and effective anti-venoms, people are aware of the anti-venom drugs.
  • – Anti-venom production is difficult and expensive. The cost of several anti-venoms has increased dramatically over the last two decades, making treatment unaffordable for most of the people who are in need of it.
  • – Inappropriate procurement and medicine distribution strategies in few countries contribute to manufacturers ceasing the production of anti-venom or increasing the prices of anti-ve

    Scope of the Report:

  • Antivenom (or antivenin or antivenene) is a biological product used to treat venomous bites or stings. Antivenom is created by extracting venom from the relevant species of animal, which includes snakes, spiders, insects, fish, etc. The market is segmented by animal and type (of venom). The animals considered are snakes, scorpion, spiders, etc. The other animals segment includes bees, marine animals, such as fish, jellyfish, and insects. The types considered are polyvalent heterologous, monovalent heterologous, homologous, and small molecule anti-toxins.

    Reasons for Buying Anti-venom Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at –

    Key Market Trends:

    Polyvalent Heterologous Antivenom Segment is Poised to Register Robust Growth.

    The term ‘heterologous’ indicates that the anti-venom is produced from an animal immunized by an organism differing from that against which it is to be used. Polyvalent anti-venoms are produced by obtaining the hyper-immunizing venom from two or more species and the resultant anti-venom contains neutralizing antibodies against the venom of two or more species. They are useful in regions where there are too many poisonous species to produce monovalent anti-venoms against all of them.

    The United States is Expected to Retain Largest Market Share During the Forecast Period

    Geographically, North America holds the largest market share with respect to demand and revenue. In the United States, every state, except Maine, Alaska, and Hawaii, is home to at least one of the 20 venomous snake species. Up to 95% of all snakebite-related deaths in the United States are attributed to the western and eastern diamondback rattlesnakes. Furthermore, the majority of bites in the United States occur in the south-western part of the country, as the rattlesnake population in the eastern states are much lower. The United States contributes a major share to the anti-venom market, due to the establishment of snake poison control centers, increase in antivenom products, and rise in clinical trial conducting firms for anti-venom products, and established healthcare facilities in the region.

    Anti-venom Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 4250 USD for single user license) –

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Anti-venom Market Report 2019-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Awareness on Antivenoms Available
    4.2.2 Technological Advancements
    4.3 Market Restraints
    4.3.1 Complexities Involved in The Preparation of the Correct Immunogens
    4.3.2 Lack of Regulatory Capacity for the Control of Antivenoms in Countries
    4.4 Porter’s Five Force Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 By Animal
    5.1.1 Snake
    5.1.2 Scorpion
    5.1.3 Spiders
    5.1.4 Other Animals
    5.2 By Antivenom Type
    5.2.1 Polyvalent Heterologous Antivenoms
    5.2.2 Monovalent Heterologous Antivenom
    5.2.3 Homologous Antivenoms
    5.2.4 Small Molecule Anti-Toxins
    5.3 Geography
    5.3.1 North America United States Canada Mexico
    5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
    5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.3.4 Middle East & Africa GCC South Africa Rest of Middle East & Africa
    5.3.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Pfizer Inc.
    6.1.2 Laboratorios Silanes (Bioclon Institute)
    6.1.3 CSL Limited
    6.1.4 BTG PLC
    6.1.5 Merck & Co.
    6.1.6 Merck KGaA (Sigma Aldrich)
    6.1.7 Flynn Pharma (Micropharm)
    6.1.8 Boehringer Ingelheim



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Traffic Signs Market Size, share 2019 – Globally Industry Demand, Emerging Trends, Regional Overview, Top Manufacture, Top Company Analysis, Business Strategy and Forecast to 2024

    Camp Management Software Industry 2019 Global Market Innovative Technologies, Supply Demand Scenario, Key Solutions, Growth Rate, Future Trends, Industry Vertical, and Region Analysis – Global Forecast to 2023

    Generator Market 2019 Industry Status by Trend Analysis, Growth Status, Revenue Expectation to 2023 | Research Report by Industry

    Electroretinography Market 2019 | Industry Overview by Market Size, Share, Industry Scope, and Regional Analysis Forecast to 2024 – Industry

  • Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *